Midkine
Midkine Informations sur la molécule
| Nom anglais | Midkine | Nombre de médicaments commercialisés | 0 |
| Nombre de médicaments cliniques | 1 | Alias de la cible | Midkine，Midgestation and kidney protein，Neurite outgrowth-promoting factor 2，Neurite outgrowth-promoting protein，Amphiregulin-associated protein，NEGF2，ARAP，FLJ27379，Neurite Growth-Promoting Factor 2，Retinoic Acid Inducible Factor，MK1，MDK，MK |
| Phase de R&D la plus avancée | Clinical | ||
| Nom anglais | Midkine |
| Alias de la cible | Midkine，Midgestation and kidney protein，Neurite outgrowth-promoting factor 2，Neurite outgrowth-promoting protein，Amphiregulin-associated protein，NEGF2，ARAP，FLJ27379，Neurite Growth-Promoting Factor 2，Retinoic Acid Inducible Factor，MK1，MDK，MK |
| Nombre de médicaments commercialisés | 0 |
| Nombre de médicaments cliniques | 1 |
| Phase de R&D la plus avancée | Clinical |
Midkine Liste de produits
- Attribut
Protein (1)
- Bibliothèque de produits
En ligne (1)
- Espèces
Human (1)
- Étiquette
Tag Free (1)
- Marqueur
Unconjugated (1)
| Numéro de produit | Espèces | Système d'expression | Description du produit | Structure protéique | Pureté | Caractéristiques | Pré-commande/Commande |
|---|---|---|---|---|---|---|---|
 Human | E. coli | Human Midkine / Mdk Protein, premium grade |  |  |  |  Ajouter au panier |
Quantité totale1
- 1
MidkineContexte de la molécule
Midkine (MK or MDK), also known as neurite growth-promoting factor 2 (NEGF2), is a protein that in humans is encoded by the MDK gene. Midkine is a basic heparin-binding growth factor of low molecular weight, and forms a family with pleiotrophin (NEGF1, 46% homologous with MK). It is a nonglycosylated protein, composed of two domains held by disulfide bridges. It is a developmentally important retinoic acid-responsive gene product strongly induced during mid-gestation, hence the name midkine. Restricted mainly to certain tissues in the normal adult, it is strongly induced during oncogenesis, inflammation and tissue repair.
MidkineAlias de la molécule
MDK,MEK,Midkine,MK1,MKARAP,NEGF2,Retinoic acid-induced differentiation factor
Informations sur les médicaments cliniques
| Nom anglais | Code de recherche | Phase de R&D | Entreprise | Indication | Essai clinique |
|---|---|---|---|---|---|
| CMK-103 | CMK-103 | Clinical | Cellmid | Myocardial Infarction | Details |
- Informations sur la molécule
- Liste de produits
- Informations sur les médicaments cliniques